Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focus on mental fatigue and pain

References

• Holm L, Cassidy JD, Carroll LJ, Borg J. Summary of the WHO Collaborating Centre for Neurotrauma Task Force on Mild Traumatic Brain Injury. Journal of Rehabiliation Medicine 2005;37:137–141
   PubMed Web of Science ®Google Scholar
• Carroll LJ, Cassidy JD, Peloso PM. Prognosis of mild traumatic brain injury: results of the WHO collaborating Centre Task Force on Mild Traumatic Brain Injury. Journal of Rehabiliation Medicine 2004;43:84–105
   PubMed Web of Science ®Google Scholar
• Lundin A, de Boussard C, Edman G, Borg J. Symptoms and disability until 3 months after mild TBI. Brain Injury 2006;20:799–806
   PubMed Web of Science ®Google Scholar
• Reitan RM, Wolfson D. The two faces of mild head injury. Archives of Clinical Neuropsychology 1999;14:191–202
   PubMed Web of Science ®Google Scholar
• Bushnik T, Englander J, Wright J. Patterns of fatigue and its correlates over the first 2 years after traumatic brain injury. Head Trauma Rehabilitation 2008;23:25–32
   PubMed Web of Science ®Google Scholar
• Stulemeijer M, van der Werf S, Bleijenberg G, Biert J, Brauer J, Vos PE. Recovery from mild traumatic brain injury: a focus on fatigue. Journal of Neurology, Neurosurgery & Psychiatry 2006;253:1041–1047
   Web of Science ®Google Scholar
• van der Naalt J, Zomeren V, AH, Sluiter WJ, Minderhoud JM. One year outcome in mild to moderate head injury: the predictive value of acute injury characteristics related to complaints and return to work. Journal of Neurology, Neurosurgery & Psychiatry 1999;66:207–213
   Google Scholar
• O’Connor C, Colantonio A, Polatajko H. Long term symptoms and limitations of activity of people with traumatic brain injury: a ten-year follow-up. Psychological Reports 2005;97:169–179
   PubMedGoogle Scholar
• Johansson B, Rönnbäck L. Mental fatigue; a common long term consequence after a brain injury. In: Agrawal A, editor. Brain Injury - Functional aspects, rehabilitation and prevention. Rijeka, Croatia: InTech; 2012. p 3–16
   Google Scholar
• Rönnbäck L, Johansson B. Long-lasting mental fatigue after traumatic brain injury or stroke – e new perspective. Saarbrucken: LAP Lambert Academic Publishing; 2012
   Google Scholar
• Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. Journal of the American Medical Association 2008;300:711–719
   PubMed Web of Science ®Google Scholar
• Belmont A, Agar N, Azouvi P. Subjective fatigue, mental effort, and attention dificits after severe traumatic brain injury. Neurorehabilitation & Neural Repair 2009;23:939–944
   PubMed Web of Science ®Google Scholar
• Azouvi P, Couillet J, Leclercq M, Martin Y, Asloun S, Rousseaux M. Divided attention and mental effort after severe traumatic brain injury. Neuropsychologia 2004;42:1260–1268
   PubMed Web of Science ®Google Scholar
• Ziino C, Ponsford J. Selective attention deficits and subjective fatigue following traumatic brain injury. Neuropsychology 2006;20:383–390
   PubMed Web of Science ®Google Scholar
• Johansson B, Berglund P, Rönnbäck L. Mental fatigue and impaired information processing after mild and moderate traumatic brain injury. Brain Injury 2009;23:1027–1040
   PubMed Web of Science ®Google Scholar
• Leonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Human Psychopharmacology: Clinical & Experimental 2004;19:151–180
   PubMed Web of Science ®Google Scholar
• Alban JP, Hopson MM, Whyte J. Effect on methylphenidate on vital signs and adverse effects in adults with traumatic brain injury. Americn Journal of Physical Medicine & Rehabilitation 2004;83:131–137
   Google Scholar
• Plenger PM, Dixon CD, Castillo RM, Frankowski RF, Yablon SA, Levin HS. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Archives of Physical Medicine & Rehabilitation 1996;77:536–540
   PubMed Web of Science ®Google Scholar
• Speech TJ, Rao SM, Osmon DC, Sperry LT. A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Injury 1993;7:333–338
   PubMedGoogle Scholar
• Whyte J, Hart T, Schuster K, Fleming M, Polansky M, Coslett HB. Effects of methylphenidate on attentional function after traumatic brain injury: a randomized, placebo-controlled trial. American Journal of Physical Medicine & Rehabilitation 1997;76:440–450
   PubMed Web of Science ®Google Scholar
• Whyte J, Hart T, Vaccaro M, Grieb-Neff P, Risser A, Polansky M, Coslett HB. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. American Journal of Physical Medicine & Rehabilitation 2004;83:401–420
   PubMed Web of Science ®Google Scholar
• Willmott C, Ponsford J. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomized, corssover, double-blind, placebo controlled inpatient trial. Journal of Neurology, Neurosurgery & Psychiatry 2009;80:552–557
   PubMed Web of Science ®Google Scholar
• Kaelin DL, Cifu DX, Matthie SB. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Archives of Physical Medicine & Rehabilitation 1996;77:6–9
   PubMed Web of Science ®Google Scholar
• Warden DL, Gordon B, McAllister TW, Silver JM, Barth JT, Bruns J, Drake A, Gentry T, Jagoda A; Neurobehavioral Guidelines Working Group. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. Journal of Neurotrauma 2006;23:1468–1501
   PubMed Web of Science ®Google Scholar
• Willmott C, Ponsford J, Olver J, Ponsford M. Safety of methylphenidate following traumatic brain injury: impact on vital signs and side-effects during inpatient rehabilitation. Journal of Rehabilitation Medicine 2009;41:585–587
   PubMed Web of Science ®Google Scholar
• Martinez-Raga J, Knech TC, Szerman N, Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs 2013;1:15–30
   Google Scholar
• Arcinegas DB, Anderson CA, Topkoff J, McAllister TW. Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuripsychiatric Disease and Treatment 2005;1:311–327
   PubMedGoogle Scholar
• Johansson B, Starmark A, Berglund P, Rödholm M, Rönnbäck L. A self-assessment questionnaire for mental fatigue and related symptoms after neurological disorders and injuries. Brain Injury 2010;24:2–12
   PubMed Web of Science ®Google Scholar
• King NS, Crawford S, Wenden FJ, Moss NEG, Wade DT. The Rivermead post concussion symptoms questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. Journal of Neurology, Neurosurgery & Psychiatry 1995;24:587–592
   Google Scholar
• Lindqvist G, Malmgren H. Organic mental disorders as hypothetical pathogenetic processes. Acta Psychiatrica Scandinavica 1993;88:5–17
   Web of Science ®Google Scholar
• Rödholm M, Starmark J-E, Svensson E, von Essen C. Asteno-emotional disorder after aneurysmal SAH: reliability, symptomatology and relation to outcome. Acta Neurologica Scandinavica 2001;103:379–385
   PubMed Web of Science ®Google Scholar
• Price DD, McGrath PA, Rafi A, Buckingham B. The validation of visualanaloguescales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45–56
   PubMed Web of Science ®Google Scholar
• Platon B, Andréll P, Raner C, Rudolph M, Dvoretsky A, Mannheimer C. High-frequency, high-intensity transcutaneous electrical nerve stimulation as treatment of pain after surgical abortion. Pain 2010;148:114–119
   PubMed Web of Science ®Google Scholar
• Åsberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica 1978;271:5–27
   Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382–389
   PubMed Web of Science ®Google Scholar
• Svanborg P, Åsberg M. A comparison between the Beck depression inventory (BDI) and the self-rating version of the Montgomery Åsberg depression rating scale (MADRS). Journal of Affective Disorders 2001;64:203–216
   PubMed Web of Science ®Google Scholar
• Senn S, Joyce JA, Senn JA. Cross-over trials in clinical research. 2nd ed. Chochester: Wiley; 2002
   Google Scholar
• Altman DG, editor. Practical statistics for medical research. New York: Chapman and Hall. 1991
   Google Scholar
• Gualtieri TH, Evans RW. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Injury 1988;2:273–290
   PubMedGoogle Scholar
• Lee H, Kim S-W, Kim J-M, Shin I-S, Yang S-J, Yoon J-S. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Human Psychopharmacology: Clinical & Experimental 2005;20:97–104
   PubMed Web of Science ®Google Scholar
• Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Journal of Clinical Psychopharmacology 2009;29:239–247
   PubMed Web of Science ®Google Scholar
• Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheethan TC, Quinn VP, Dublin S, Boudreau DM, et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. Journal of the American Medical Association 2011;306:2673–2683
   PubMed Web of Science ®Google Scholar